Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Bristol Myers Squibb - The Treatment Paradigm Shift: Unlocking New Chapters with I-O in Thoracic Cancers

Multidisciplinary Conversation: Putting I-O on the Table for Patients with Resectable NSCLC

Date

10 Sep 2022

Session

Bristol Myers Squibb - The Treatment Paradigm Shift: Unlocking New Chapters with I-O in Thoracic Cancers

Topics

Tumour Site

Non-Small Cell Lung Cancer; Mesothelioma

Presenters

Jonathan Spicer

Authors

J. Spicer

Author affiliations

McGill University, H3A 1X1 - Montreal/CA

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Login

Resources from the same session

10 Sep 2022

Welcome and Introductions

Presenter: Virginie Westeel

Session: Bristol Myers Squibb - The Treatment Paradigm Shift: Unlocking New Chapters with I-O in Thoracic Cancers

Resources:

Webcast

10 Sep 2022

Considering the Options: Survivorship in Metastatic NSCLC and Potential Approaches for I-O–Experienced Patients

Presenter: Virginie Westeel

Session: Bristol Myers Squibb - The Treatment Paradigm Shift: Unlocking New Chapters with I-O in Thoracic Cancers

Resources:

Webcast

10 Sep 2022

Making Progress for Patients: How I-O Has Changed Outcomes in Unresectable MPM

Presenter: Dean Fennell

Session: Bristol Myers Squibb - The Treatment Paradigm Shift: Unlocking New Chapters with I-O in Thoracic Cancers

Resources:

Webcast

10 Sep 2022

Live Q&A and Closing Remarks

Presenter: Dean Fennell

Session: Bristol Myers Squibb - The Treatment Paradigm Shift: Unlocking New Chapters with I-O in Thoracic Cancers

Resources:

Webcast